ClinicalTrials.gov
public full text
Public Domain
Naltrexone and Adrenergic Agents to Reduce Heroin Use in Heroin Addicts
Naltrexone is a medication that is currently used to treat drug and alcohol addiction. Guanfacine is a medication that is currently used to manage the withdrawal symptoms in individuals undergoing opioid detoxification. A combination of these two medications may be beneficial in reducing heroin use in individuals addicted to heroin. This study will evaluate the effectiveness of naltrexone and guanfacine, alone and in combination, at reducing heroin use in heroin addicts.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Guanfacine for the Treatment of Post Traumatic Stress Disorder (PTSD)#1228513
- Effects of N-acetylcysteine on Brain Chemistry and Behavior in Cocaine Abusers (NAC)#894155
- Study to Evaluate the Pharmacokinetics of Guaifenesin in Adults and Adolescents#813437
- Adherence to HIV Therapy in Heroin Addicts: Oral vs XR-NTX#842866
- Guanfacine Extended Release and Mindfulness Skills Therapy#1369310
Record · ID 1306804
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive